{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "4602944", "DateCompleted": {"Year": "1974", "Month": "10", "Day": "10"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0025-8458", "JournalIssue": {"Volume": "69", "Issue": "21", "PubDate": {"Year": "1974", "Month": "May", "Day": "24"}}, "Title": "Medizinische Klinik", "ISOAbbreviation": "Med Klin"}, "ArticleTitle": "[The cerebral blood-flow-volume in patients with sclerotic changes after treatment with raubasin (Lamuran)].", "Pagination": {"StartPage": "947", "EndPage": "952", "MedlinePgn": "947-52"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Klemm", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Scheuring", "ForeName": "H J", "Initials": "HJ"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Controlled Clinical Trial", "English Abstract", "Journal Article", "Randomized Controlled Trial"], "VernacularTitle": "Das Verhalten des Hirndurchblutungsvolumens unter Behandlung mit Raubasin (Lamuran) bei Sklerose der Zerebralgef\u00e4sse."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Med Klin", "NlmUniqueID": "0376637", "ISSNLinking": "0025-8458"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Placebos"}, {"RegistryNumber": "0", "NameOfSubstance": "Radioisotopes"}, {"RegistryNumber": "0", "NameOfSubstance": "Secologanin Tryptamine Alkaloids"}, {"RegistryNumber": "142M471B3J", "NameOfSubstance": "Carbon Dioxide"}, {"RegistryNumber": "3H3U766W84", "NameOfSubstance": "Xenon"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Arteries"}, {"QualifierName": ["blood"], "DescriptorName": "Carbon Dioxide"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cerebrovascular Circulation"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Injections, Intravenous"}, {"QualifierName": ["diagnosis", "drug therapy"], "DescriptorName": "Intracranial Arteriosclerosis"}, {"QualifierName": [], "DescriptorName": "Partial Pressure"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Placebos"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Radioisotopes"}, {"QualifierName": [], "DescriptorName": "Radionuclide Imaging"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Rauwolfia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Regional Blood Flow"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Secologanin Tryptamine Alkaloids"}, {"QualifierName": [], "DescriptorName": "Xenon"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1974", "Month": "5", "Day": "24"}, {"Year": "2000", "Month": "3", "Day": "22", "Hour": "9", "Minute": "0"}, {"Year": "1974", "Month": "5", "Day": "24", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4602944"]}}]}